Loading clinical trials...
Loading clinical trials...
Multicenter Evaluation Study of the CADe System ENDOMIND in Surveillance Endoscopy for Colorectal Cancer in German Outpatient Cohort
Evaluation of an artificial intelligence system for polyp detection (CADe)
We aim to evaluate the artificial intelligence system ENDOMIND that supports endoscopist in detection of polyps during surveillance endoscopy for colorectal cancer. 1070 patients out of 6 gastroenterologic practice are randomized 1:1 for conventional surveillance colonoscopy vs. surveillance with AI support. Primary endpoint is Adenoma detection rate.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
Yes
Universitätsklinikum Würzburg
Würzburg, Bavaria, Germany
Start Date
September 1, 2021
Primary Completion Date
November 30, 2022
Completion Date
November 30, 2022
Last Updated
April 27, 2023
1,149
ACTUAL participants
ENDOMIND
DEVICE
Lead Sponsor
Wuerzburg University Hospital
Collaborators
NCT07432165
NCT07236840
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07079592